LHA Market State Tactical Beta ETF (MSTB)

The LHA Market State Tactical Beta ETF (ticker MSTB) is an exchange-traded fund designed to capture what its managers call the “market’s hidden returns” — gains that come not from picking individual stocks but from systematic tilts toward market factors that have historically rewarded disciplined investors. Rather than holding every company in the market with equal weight, MSTB applies rules to favour companies displaying certain financial characteristics — value, momentum, quality, or low volatility — in an attempt to deliver returns above those of a standard market-cap-weighted index while staying true to the principles of transparent, rules-based investing.

What tactical beta means

Tactical beta sits between two older approaches to investing: the strict passive indexing that dominated the 1980s and 90s, and active stock-picking, where a human manager tries to outguess the market. Tactical beta says: we won’t pick stocks, but we’ll tilt the portfolio systematically toward factors — value, momentum, quality, low volatility — that academic research and decades of market data suggest have offered extra returns per unit of risk. The tilt is applied through a mathematical rule that investors can see, understand, and audit. There are no black-box decisions. Every company that meets the criteria gets included according to its score; every rebalance follows the same formula.

MSTB’s particular version of this philosophy rests on a mix of such factors, weighted to balance the trade-off between diversification and concentrated bets on a handful of characteristics. The fund may overweight value stocks (those trading below historic earnings or book value), companies with strong momentum (rising prices and earnings), or firms with stable earnings and predictable cash flows. The exact combination changes as market conditions shift — hence “tactical” — so the fund is designed to respond to changing valuations or volatility regimes without requiring a human portfolio manager to make a call.

Holdings and portfolio construction

Because MSTB is factor-tilted rather than stock-picked, its portfolio is large and diversified — typically holding hundreds of stocks, often spanning both large-cap and mid-cap equities. That diversification matters: a single-factor bet (say, pure value) can underperform for years when growth stocks are in favour, but a balanced blend of factors tends to soften such drawdowns. Investors in MSTB are not betting everything on the market suddenly recognising that cheap stocks are better — they are betting that a systematic, well-diversified approach to capturing multiple rewarded factors will outpace a simple cap-weighted index over a market cycle or two.

The fund’s holdings shift as companies’ characteristics change and as the rebalancing schedule kicks in (usually quarterly or semi-annually). Investors can see the full holdings list and the rules governing inclusion on the LHA website or via ETF data providers. That transparency is a cornerstone of the tactical beta philosophy: if your strategy works, you should be willing to publish it.

Costs and considerations

MSTB charges an annual expense ratio that reflects both the systematic nature of the strategy and the cost of frequent rebalancing. While cheaper than a traditional active mutual fund run by a stock-picker, tactical-beta funds do cost a touch more than a plain vanilla market-cap-weighted index ETF. The key question for an investor is whether the factor tilts offer a return premium large enough to cover those costs plus market impact and transaction friction from rebalancing.

Like any equity ETF, MSTB is most tax-efficient when held in a retirement account (where trades and distributions do not trigger capital-gains tax). In a taxable brokerage account, the periodic rebalancing — necessary to keep the factor tilts at their target levels — can create distributed capital gains. That is not a knock against tactical beta in general, but it is a trade-off to know about.

Risks specific to factor tilting

The most important risk is factor drought. If the market enters a regime where the factors MSTB emphasizes — value, momentum, or quality — underperform for an extended period, the fund will underperform the broader market. This has happened before: value was deep underwater for much of the 2010s as growth stocks and technology leaders soared. An investor who bought a value-tilted fund near 2010 and held through 2020 endured years of underperformance before the cycle shifted. That is not a flaw in tactical beta itself — it is the price of a systematic bet on factors rather than the market overall.

A second risk is that factor premiums may be shrinking. As billions of dollars have poured into smart-beta and factor-tilted funds, the very factors these funds overweight become crowded. If everyone is trying to buy cheap stocks, cheap stocks may no longer stay cheap for long. Whether factor premiums have compressed enough to matter is hotly debated among academics and practitioners, but it is worth keeping in mind.

Transaction costs and slippage from frequent rebalancing can also eat into returns, especially in market dislocations when liquidity dries up. During a flash crash or a market panic, the spreads on the stocks MSTB holds widen, and the cost to rebalance can spike.

Research and suitability

MSTB is appropriate for investors who believe in factor premiums and are willing to hold through extended periods when their chosen factors underperform. It works best in a diversified portfolio alongside traditional index funds and bonds, not as a sole equity holding. Potential investors should read the fund’s prospectus and fact sheet to understand the exact factors being targeted, the weighting scheme, and the rebalancing frequency. Those details vary between tactical-beta funds and determine how a fund will behave in different market environments.

The academic foundation for factor investing is strong, and numerous studies have documented that value, momentum, and quality tilts have worked over long periods. But past results are not a promise. Anyone considering MSTB should understand that tactical beta is fundamentally a bet that factors will continue to offer premiums in the future — and should be comfortable with the possibility that they will not.